Asymmetric Reductive Amination for Sitagliptin Intermediate Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing sitagliptin intermediate are inefficient due to high toxicity, safety risks, low yields, and high production costs, particularly in the steps involving borane reagents, expensive catalysts, long reaction routes, and energy-intensive processes.
Innovation Solution
The method employs asymmetric reductive amination using a transition metal catalyst with a chiral phosphine ligand, such as Ru(OAc)2 ((R)-dm-Segphos), in the presence of hydrogen and an acidic additive like salicylic acid, to directly produce the sitagliptin intermediate with high enantiomeric excess and yield, reducing the number of steps and avoiding the need for separation and amino-protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If borane reagent is used in the reduction step, then the chiral center can be constructed, but the toxicity and safety risks increase significantly
Solution Approach 1:
The patent changes the chemical parameters by replacing borane reagent with hydrogen gas and a chiral catalyst system. This substitution maintains the ability to construct the chiral center at C3 while eliminating the toxicity and safety risks associated with borane handling and disposal.
Solution Approach 2:
The patent substitutes the chemical mechanism involving borane reduction with a catalytic hydrogenation mechanism. This replacement uses hydrogen gas and a chiral catalyst (such as Ru-BINAP or other metal complexes) to achieve the same stereochemical outcome through a different chemical pathway that is safer and more environmentally friendly.
2Manufacturing precision
If racemate separation is performed to obtain the chiral intermediate, then the enantiomeric purity can be achieved, but the yield and economic efficiency deteriorate
Solution Approach 1:
The patent applies preliminary action by introducing a chiral catalyst before the reduction step occurs. This allows the chiral center to be formed with high enantiomeric excess directly during the synthesis process, rather than requiring subsequent separation of racemic mixtures. The chiral catalyst selectively promotes formation of the desired enantiomer from the start.
Solution Approach 2:
The patent extracts the need for racemate separation by using asymmetric catalysis. Instead of forming a racemate and then separating it, the chiral catalyst system directly produces the desired enantiomer, extracting the separation step entirely from the synthesis pathway and improving both yield and economic efficiency.
3Manufacturing precision
If multiple reaction steps are used to prepare the chiral intermediate, then the chiral center can be constructed, but the reaction route becomes long and complex
Solution Approach 1:
The patent merges multiple reaction steps into a single asymmetric reduction step. By using a chiral catalyst system, the synthesis of the chiral intermediate can be achieved in one operation rather than requiring multiple sequential steps for substrate preparation, chiral center formation, and purification. This consolidation simplifies the overall reaction route.
4Manufacturing precision
If expensive chiral catalysts and reagents are used, then the enantiomeric excess can be achieved, but the production cost increases
Solution Approach 1:
The patent employs catalytic systems that can be used in small amounts and are potentially recoverable or disposable. The chiral catalyst (such as Ru-BINAP complex) can be used in catalytic quantities rather than stoichiometric amounts, significantly reducing the cost of chiral reagents. The catalyst may be recovered and reused, further lowering production costs while maintaining high enantiomeric excess.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a green synthesis with high atom utilization, short steps, high yield, ease of operation, and environmental friendliness, making it suitable for industrial production with high enantiomeric purity and reduced waste generation.
Implementation Method 1
in the presence of hydrogen and a transition metal catalyst having a chiral phosphine ligand, such as Ru(OAc)2 ((R)-dm-Segphos), to directly produce the sitagliptin intermediate
Implementation Method 2
asymmetric reductive amination using a transition metal catalyst with a chiral phosphine ligand
Implementation Method 3
in the presence of hydrogen and a transition metal catalyst having a chiral phosphine ligand
Data Source
AI summary
Disclosed is a method for synthesizing a sitagliptin intermediate, the method comprising: in the presence of hydrogen and a transition metal catalyst having a chiral phosphine ligand, subjecting a compound of formula II to an asymmetric reductive amination with ammonia or ammonium salt in a proper organic solvent under the condition of adding an acidic additive to produce a compound of formula I, wherein, an R- or S-configuration of a stereocenter is represented by *; the compound of formula I of R configuration can be used to prepare sitagliptin, and a reaction formula is as follows: R1 and R2 are each independently selected from hydrogen, C1-C12 linear or branched alkyl, C3-C12 cycloalkyl, C2-C12 alkenyl, C2-C12 alkynyl and C7-C12 arylalkyl. The method has a high yield and a high ee% value, a mild reaction condition and a low production cost, and is simple to operate, convenient to purify, environmental friendly and suitable for industrial production.